A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder
- Promotore
- MGGM LLC COMPANY
- Acronimo
- REL-1017-305
- Struttura
- Psichiatria
- Sperimentatore principale
- Santinon Patrizia